Patients (N) | |
Total recruited | 41 |
With PET data available | 36 |
With PET and mRNA sequencing data available | 31 |
Analysed | 30 |
ER/HER2 status (N) | |
ER positive/negative | 22/8 |
HER2 positive/negative | 5/25 |
Triple negative (ER negative and HER2 negative) | 8 |
Tumour type (N) | |
Ductal/lobular/mixed carcinoma | 24/4/2 |
Grade 1/2/3 | 1/15/14 |
Characteristics of 30Â patients analysed (median, range) | |
Age at study entry (years) | 50 (34–67) |
Tumour size on MRI scan (mm) | 48 (30–118) |
Body mass index | 26.2 (19.6–44.9) |